Coronavirus/COVID-19, Drug Pricing, Centers for Medicare & Medicaid Services (CMS)

Trump Administration Executive Order Tracker

McDermott+ on 5/12/2025

Below is a tracker of healthcare-related executive orders (EOs) issued by the Trump administration, including overviews of each EO and the date each EO was signed. We will regularly update this tracker as additional EOs are...more

Navigating the Health Care Impacts of President Trump's First Executive Actions

Brownstein Hyatt Farber Schreck on 1/30/2025

Since taking office for his second term on Jan. 20, 2025, President Donald Trump has issued a series of executive orders (EOs) aimed at undoing several health care policies implemented by the Biden administration, indicating...more

Hospital and Health Systems Reimbursement Check - NOVEMBER 2024

Ropes & Gray LLP on 11/5/2024

Ropes & Gray attorneys share their analysis of administrative and court litigation, regulatory developments, key developments affecting federal program payments to hospitals and health systems, and other reimbursement-related...more

Regulatory Reflections from the Past Year

McDermott+ on 12/21/2023

As 2023 comes to a close, I can’t help but reflect on all the regulations and policies we reviewed this year (and those that we’ll continue to handle next week before the year actually ends). There were some tasty eggs with...more

Health Care Week In Review: HHS Selects the First 10 Drugs for Medicare Drug Price Negotiation

Alston & Bird on 9/6/2023

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

Holland & Knight Health Dose: May 16, 2023

Holland & Knight LLP on 5/19/2023

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Healthcare Preview for the Week of: May 1, 2023

McDermott+ on 5/1/2023

Lots of Healthcare Activity in Congress - Activity in Congress focusing on healthcare issues has increased over the last few weeks and is not slowing down anytime soon. This week, the Senate Health, Education, Labor, and...more

Holland & Knight Health Dose: March 28, 2023

Holland & Knight LLP on 3/30/2023

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Holland & Knight Health Dose: March 14, 2023

Holland & Knight LLP on 3/15/2023

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include ... ...more

Holland & Knight Health Dose: January 31, 2023

Holland & Knight LLP on 2/2/2023

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include:...more

Holland & Knight Health Dose: January 24, 2023

Holland & Knight LLP on 1/26/2023

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include: ...more

Hot Topics in Health Care January 2023

Burr & Forman on 1/18/2023

Court Remands Remedy for Unlawful 340B Rule to HHS - On January 10, 2023, the DC District Court remanded the issue of how to remedy five years of underpayments to 340B hospitals to the Department of Health and Human...more

With Inflation Reduction Act Signed, Other Health Policy Issues Ahead for Congress

Holland & Knight LLP on 8/17/2022

Congress ended a busy work period after passing the Inflation Reduction Act (IRA) last week. This Holland & Knight alert summarizes the healthcare provisions in the IRA and provides an outlook on health policy issues that may...more

CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors

Sheppard Mullin Richter & Hampton LLP on 5/16/2022

On April 29, 2022, the Centers for Medicare and Medicaid Services (“CMS”), issued the final rule on Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs...more

CMS Issues Final Rule for Medicare Advantage and Part D Plans

King & Spalding on 5/11/2022

On April 29, 2022, CMS issued its final rule for Medicare Advantage (MA) and Part D plans with updates including reduced out-of-pocket costs for prescription drugs and improved consumer protections. CMS published the final...more

Washington Healthcare Update - February 2022 #2

McGuireWoods Consulting on 2/15/2022

This Week in Washington: Continuing Resolution Moves Forward and Senate Sets Up Vote on FDA Commissioner Nomination this Week...more

2022 Congressional Outlook and Top 10 Federal Health Policy Issues to Watch

Holland & Knight LLP on 1/7/2022

As Congress reconvenes, it faces a packed agenda in a legislative year that will be shortened by the upcoming midterm elections and remains buffeted by the persistent coronavirus pandemic. The list of healthcare priorities is...more

Washington Healthcare Update - November 2021 #2

McGuireWoods Consulting on 11/9/2021

This week in Washington: Congressional Democrats reach drug pricing agreement; bipartisan infrastructure bill goes to President Biden’s desk with budget reconciliation bill delayed....more

Washington Healthcare Update - October 2021 #3

McGuireWoods Consulting on 10/19/2021

This week in Washington: Debt ceiling measure signed by President Biden; default averted for at least a month. Discussions about budget reconciliation continue....more

Washington Healthcare Update - August 2021 #4

McGuireWoods Consulting on 8/31/2021

This week in Washington: House passes budget resolution with compromise, setting up a September deadline for infrastructure bill vote....more

Executive Order on Promoting Competition in the American Economy: The Biden Administration Considers Drug Pricing Strategies While...

Sheppard Mullin Richter & Hampton LLP on 8/20/2021

On August 10, 2021, the Centers for Medicare and Medicaid (“CMS”) published a proposed rule (“Proposed Rule”) to rescind the Most Favored Nation Model (“MFN Model”) interim final rule that was published on November 26, 2020...more

Washington Healthcare Update - June 2021 #4

McGuireWoods Consulting on 6/29/2021

This week in Washington: Infrastructure deal struck, but it still has a long road ahead to passage; Senate Budget Committee discussed draft resolution with health initiatives included....more

Senate Finance Committee Holds Confirmation Hearing For Top Biden HHS Nominees

ArentFox Schiff on 4/16/2021

Deputy Secretary and CMS Administrator Picks Would Fill Two Critical Policy Positions - On Thursday, the Senate Finance Committee held a confirmation hearing for two of the most important health policy officials nominated...more

Relevant Highlights: Hearing to Consider the Nomination of Chiquita Brooks-LaSure to be Administrator for the Centers for Medicare...

Foley & Lardner LLP on 4/16/2021

This morning, the United States Senate Committee on Finance questioned Pres. Biden’s nominee, Chiquita Brooks-LaSure, for Administrator for Centers for Medicare and Medicaid Services (CMS), as well as Andrea Palm, the nominee...more

Washington Healthcare Update - March 2021 #4

McGuireWoods Consulting on 3/23/2021

This week in Washington: Becerra confirmed 50-49 to be Secretary of Health and Human Services...more

Coronavirus/COVID-19 › Drug Pricing › Centers for Medicare & Medicaid Services (CMS)

"My best business intelligence, in one easy email…"